These results revealed a role for CD70 in melanoma invasiveness via its interaction with MAPK pathway activation and suggested that anti-CD70 antibodies should be selected to eliminate those that induce CD70 trimerization and consequently promote tumor invasion. This evidence concerns the gene CD70 and melanoma.